Business Description
Praxis Precision Medicines is a Boston-based drug development company focused on treating brain disorders where nerve activity becomes dangerously unbalanced. The company is advancing several treatments for conditions such as epilepsy and essential tremor, with multiple drug candidates currently in late-stage clinical trials and others awaiting regulatory approval. Praxis works across two development platforms ? one focused on oral small molecule drugs and another on genetic medicine ? and maintains research partnerships with RogCon and Ionis Pharmaceuticals. Founded in 2015, the company also has a pipeline of earlier-stage programs targeting rare genetic conditions affecting brain function.
